In 2024, the global market size of Self Injection Device was estimated to be worth US$ 9600 million and is forecast to reach approximately US$ 13090 million by 2031 with a CAGR of 4.6% during the forecast period 2025-2031.
The injectors were initially designed to overcome the hesitation associated with self-administration of the needle-based drug delivery device.
An auto-injector is a medical device designed to deliver a dose of a particular drug.
Market competition is not intense. Novo Nordisk, Mylan, Pfizer, Sanofi, BD, Eli Lilly and Gerresheimer, etc. are the leaders of the industry, with about 60% market shares.
Europe is the largest consumption place, with a consumption market share nearly 42%. Following Europe, North America is the second largest consumption place with the consumption market share of 31%.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Self Injection Device, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Self Injection Device.
The Self Injection Device market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Self Injection Device market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Self Injection Device manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and regions.
By Company
Novo Nordisk
Mylan
Pfizer
Sanofi
BD
Eli Lilly
Gerresheimer
Dongbao
Ypsomed
Owen Mumford
Antares Pharma
Haselmeier
Segment听by Type
Reusable Self Injection Device
Disposable Self Injection Device
Segment听by Application
Insulin Injection
Epinephrine Injection
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Self Injection Device in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 3: Detailed analysis of Self Injection Device manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Self Injection Device sales, revenue, price, gross margin, sales by region, by Type, by Application, and recent development, etc.
Chapter 5: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: APAC by Type, by Application and by country, sales, and revenue for each segment.
Chapter 9: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 10: Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Middle East and Africa by Type, by Application and by country, sales, and revenue for each segment.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: Research Findings and Conclusion.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Study Coverage
1.1 Self Injection Device Product Introduction
1.2 Market by Type
1.2.1 Global Self Injection Device Market Size Growth Rate by Type (2020 VS 2024 VS 2031)
1.2.2 Reusable Self Injection Device
1.2.3 Disposable Self Injection Device
1.3 Market by Application
1.3.1 Global Self Injection Device Market Size Growth Rate by Application (2020 VS 2024 VS 2031)
1.3.2 Insulin Injection
1.3.3 Epinephrine Injection
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Self Injection Device Market Size Estimates and Forecasts
2.1.1 Global Self Injection Device Revenue 2020-2031
2.1.2 Global Self Injection Device Sales 2020-2031
2.2 Self Injection Device Market Size by Region: 2024 Versus 2031
2.3 Self Injection Device Sales by Region (2020-2031)
2.3.1 Global Self Injection Device Sales by Region: 2020-2025
2.3.2 Global Self Injection Device Sales Forecast by Region (2026-2031)
2.3.3 Global Self Injection Device Sales Market Share by Region (2020-2031)
2.4 Self Injection Device Market Estimates and Projections by Region (2026-2031)
2.4.1 Global Self Injection Device Revenue by Region: 2020-2025
2.4.2 Global Self Injection Device Revenue Forecast by Region (2026-2031)
2.4.3 Global Self Injection Device Revenue Market Share by Region (2020-2031)
3 Market Segments
3.1 Breakdown Data by Type
3.1.1 Global Self Injection Device Sales by Type (2020-2031)
3.1.1.1 Global Self Injection Device Sales Volume by Type (2020-2031)
3.1.1.2 Global Self Injection Device Sales Market Share by Type (2020-2031)
3.1.2 Global Self Injection Device Revenue by Type (2020-2031)
3.1.2.1 Global Self Injection Device Revenue by Type (2020-2031)
3.1.2.2 Global Self Injection Device Revenue Market Share by Type (2020-2031)
3.1.3 Self Injection Device Average Selling Price (ASP) by Type (2020-2031)
3.2 Breakdown Data by Application
3.2.1 Global Self Injection Device Sales by Application (2020-2031)
3.2.1.1 Global Self Injection Device Sales Volume by Application (2020-2031)
3.2.1.2 Global Self Injection Device Sales Market Share by Application (2020-2031)
3.2.2 Global Self Injection Device Revenue by Application (2020-2031)
3.2.2.1 Global Self Injection Device Revenue by Application (2020-2031)
3.2.2.2 Global Self Injection Device Revenue Market Share by Application (2020-2031)
3.2.3 Self Injection Device Average Selling Price (ASP) by Application (2020-2031)
3.3 by Type and by Application Crossing Analysis
3.3.1 Reusable Self Injection Device of Self Injection Device Revenue Market Share by Application
3.3.2 Disposable Self Injection Device of Self Injection Device Revenue Market Share by Application
4 Global Self Injection Device by Manufacturers
4.1 Global Top Self Injection Device Manufacturers by Sales (2020-2025)
4.1.1 Global Self Injection Device Sales by Manufacturer (2020-2025)
4.1.2 Global Self Injection Device Sales Market Share by Manufacturer (2020-2025)
4.2 Global Top Self Injection Device Manufacturers by Revenue (2020-2025)
4.2.1 Global Self Injection Device Revenue by Manufacturer (2020-2025)
4.2.2 Global Self Injection Device Revenue Share by Manufacturer (2020-2025)
4.3 Global Self Injection Device Price by Manufacturer (2020-2025)
4.4 Competitive Landscape
4.4.1 Key Self Injection Device Manufacturers Covered: Ranking by Revenue
4.4.2 Global Self Injection Device Market Concentration Ratio (CR5 and HHI) & (2020-2025)
4.4.3 Global Self Injection Device Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.5 Global Self Injection Device Manufacturing Base Distribution, Product Type
4.5.1 Self Injection Device Manufacturers Manufacturing Base Distribution, Headquarters
4.5.2 Date of International Manufacturers Enter into Self Injection Device Market
4.5.3 Manufacturers Self Injection Device Product Type and Application
4.5.4 Reusable Self Injection Device Market Sales of Self Injection Device by Manufacturer
4.5.5 Disposable Self Injection Device Market Sales of Self Injection Device by Manufacturer
4.6 Manufacturers Mergers & Acquisitions, Expansion Plans
5 Company Profiles
5.1 Novo Nordisk
5.1.1 Novo Nordisk Company Information
5.1.2 Novo Nordisk Description, Business Overview
5.1.3 Novo Nordisk Self Injection Device Products Offered
5.1.4 Novo Nordisk Self Injection Device Sales, Revenue and Gross Margin (2020-2025)
5.1.5 Novo Nordisk Self Injection Device Sales by Product in 2024
5.1.6 Novo Nordisk Self Injection Device Sales by Application in 2024
5.1.7 Novo Nordisk Self Injection Device Sales by Geographic Area in 2024
5.1.8 Novo Nordisk Recent Developments
5.2 Mylan
5.2.1 Mylan Company Information
5.2.2 Mylan Description, Business Overview
5.2.3 Mylan Self Injection Device Products Offered
5.2.4 Mylan Self Injection Device Sales, Revenue and Gross Margin (2020-2025)
5.2.5 Mylan Self Injection Device Sales by Product in 2024
5.2.6 Mylan Self Injection Device Sales by Application in 2024
5.2.7 Mylan Self Injection Device Sales by Geographic Area in 2024
5.2.8 Mylan Recent Developments
5.3 Pfizer
5.3.1 Pfizer Company Information
5.3.2 Pfizer Description, Business Overview
5.3.3 Pfizer Self Injection Device Products Offered
5.3.4 Pfizer Self Injection Device Sales, Revenue and Gross Margin (2020-2025)
5.3.5 Pfizer Self Injection Device Sales by Product in 2024
5.3.6 Pfizer Self Injection Device Sales by Application in 2024
5.3.7 Pfizer Self Injection Device Sales by Geographic Area in 2024
5.3.8 Pfizer Recent Developments
5.4 Sanofi
5.4.1 Sanofi Company Information
5.4.2 Sanofi Description, Business Overview
5.4.3 Sanofi Self Injection Device Products Offered
5.4.4 Sanofi Self Injection Device Sales, Revenue and Gross Margin (2020-2025)
5.4.5 Sanofi Self Injection Device Sales by Product in 2024
5.4.6 Sanofi Self Injection Device Sales by Application in 2024
5.4.7 Sanofi Self Injection Device Sales by Geographic Area in 2024
5.4.8 Sanofi Recent Developments
5.5 BD
5.5.1 BD Company Information
5.5.2 BD Description, Business Overview
5.5.3 BD Self Injection Device Products Offered
5.5.4 BD Self Injection Device Sales, Revenue and Gross Margin (2020-2025)
5.5.5 BD Self Injection Device Sales by Product in 2024
5.5.6 BD Self Injection Device Sales by Application in 2024
5.5.7 BD Self Injection Device Sales by Geographic Area in 2024
5.5.8 BD Recent Developments
5.6 Eli Lilly
5.6.1 Eli Lilly Company Information
5.6.2 Eli Lilly Description, Business Overview
5.6.3 Eli Lilly Self Injection Device Products Offered
5.6.4 Eli Lilly Self Injection Device Sales, Revenue and Gross Margin (2020-2025)
5.6.5 Eli Lilly Self Injection Device Sales by Product in 2024
5.6.6 Eli Lilly Self Injection Device Sales by Application in 2024
5.6.7 Eli Lilly Self Injection Device Sales by Geographic Area in 2024
5.6.8 Eli Lilly Recent Developments
5.7 Gerresheimer
5.7.1 Gerresheimer Company Information
5.7.2 Gerresheimer Description, Business Overview
5.7.3 Gerresheimer Self Injection Device Products Offered
5.7.4 Gerresheimer Self Injection Device Sales, Revenue and Gross Margin (2020-2025)
5.7.5 Gerresheimer Self Injection Device Sales by Product in 2024
5.7.6 Gerresheimer Self Injection Device Sales by Application in 2024
5.7.7 Gerresheimer Self Injection Device Sales by Geographic Area in 2024
5.7.8 Gerresheimer Recent Developments
5.8 Dongbao
5.8.1 Dongbao Company Information
5.8.2 Dongbao Description, Business Overview
5.8.3 Dongbao Self Injection Device Products Offered
5.8.4 Dongbao Self Injection Device Sales, Revenue and Gross Margin (2020-2025)
5.8.5 Dongbao Self Injection Device Sales by Product in 2024
5.8.6 Dongbao Self Injection Device Sales by Application in 2024
5.8.7 Dongbao Self Injection Device Sales by Geographic Area in 2024
5.8.8 Dongbao Recent Developments
5.9 Ypsomed
5.9.1 Ypsomed Company Information
5.9.2 Ypsomed Description, Business Overview
5.9.3 Ypsomed Self Injection Device Products Offered
5.9.4 Ypsomed Self Injection Device Sales, Revenue and Gross Margin (2020-2025)
5.9.5 Ypsomed Self Injection Device Sales by Product in 2024
5.9.6 Ypsomed Self Injection Device Sales by Application in 2024
5.9.7 Ypsomed Self Injection Device Sales by Geographic Area in 2024
5.9.8 Ypsomed Recent Developments
5.10 Owen Mumford
5.10.1 Owen Mumford Company Information
5.10.2 Owen Mumford Description, Business Overview
5.10.3 Owen Mumford Self Injection Device Products Offered
5.10.4 Owen Mumford Self Injection Device Sales, Revenue and Gross Margin (2020-2025)
5.10.5 Owen Mumford Self Injection Device Sales by Product in 2024
5.10.6 Owen Mumford Self Injection Device Sales by Application in 2024
5.10.7 Owen Mumford Self Injection Device Sales by Geographic Area in 2024
5.10.8 Owen Mumford Recent Developments
5.11 Antares Pharma
5.11.1 Antares Pharma Company Information
5.11.2 Antares Pharma Description, Business Overview
5.11.3 Antares Pharma Self Injection Device Products Offered
5.11.4 Antares Pharma Self Injection Device Sales, Revenue and Gross Margin (2020-2025)
5.11.5 Antares Pharma Self Injection Device Sales by Product in 2024
5.11.6 Antares Pharma Self Injection Device Sales by Application in 2024
5.11.7 Antares Pharma Self Injection Device Sales by Geographic Area in 2024
5.11.8 Antares Pharma Recent Developments
5.12 Haselmeier
5.12.1 Haselmeier Company Information
5.12.2 Haselmeier Description, Business Overview
5.12.3 Haselmeier Self Injection Device Products Offered
5.12.4 Haselmeier Self Injection Device Sales, Revenue and Gross Margin (2020-2025)
5.12.5 Haselmeier Self Injection Device Sales by Product in 2024
5.12.6 Haselmeier Self Injection Device Sales by Application in 2024
5.12.7 Haselmeier Self Injection Device Sales by Geographic Area in 2024
5.12.8 Haselmeier Recent Developments
6 North America
6.1 North America Self Injection Device Market Size YoY Growth 2020-2031
6.2 North America Self Injection Device Market Facts & Figures by Country
6.2.1 North America Self Injection Device Sales by Country (2020-2031)
6.2.2 North America Self Injection Device Revenue by Country (2020-2031)
6.3 North America Self Injection Device Sales by Type (2020-2025)
6.4 North America Self Injection Device Sales by Application (2020-2025)
7 Asia-Pacific
7.1 Asia-Pacific Self Injection Device Market Size YoY Growth 2020-2031
7.2 Asia-Pacific Self Injection Device Market Facts & Figures by Region
7.2.1 Asia-Pacific Self Injection Device Sales by Region (2020-2031)
7.2.2 Asia-Pacific Self Injection Device Revenue by Region (2020-2031)
7.3 Asia-Pacific Self Injection Device Sales by Type (2020-2025)
7.4 Asia-Pacific Self Injection Device Sales by Application (2020-2025)
8 Europe
8.1 Europe Self Injection Device Market Size YoY Growth 2020-2031
8.2 Europe Self Injection Device Market Facts & Figures by Country
8.2.1 Europe Self Injection Device Sales by Country (2020-2031)
8.2.2 Europe Self Injection Device Revenue by Country (2020-2031)
8.3 Europe Self Injection Device Sales by Type (2020-2025)
8.4 Europe Self Injection Device Sales by Application (2020-2025)
9 Latin America
9.1 Latin America Self Injection Device Market Size YoY Growth 2020-2031
9.2 Latin America Self Injection Device Market Facts & Figures by Country
9.2.1 Latin America Self Injection Device Sales by Country (2020-2031)
9.2.2 Latin America Self Injection Device Revenue by Country (2020-2031)
9.3 Latin America Self Injection Device Sales by Type (2020-2025)
9.4 Latin America Self Injection Device Sales by Application (2020-2025)
10 Middle East and Africa
10.1 Latin America Self Injection Device Market Size YoY Growth 2020-2031
10.2 Middle East and Africa Self Injection Device Market Facts & Figures by Country
10.2.1 Middle East and Africa Self Injection Device Sales by Country (2020-2031)
10.2.2 Middle East and Africa Self Injection Device Revenue by Country (2020-2031)
10.3 Middle East and Africa Self Injection Device Sales by Type (2020-2025)
10.4 Middle East and Africa Self Injection Device Sales by Application (2020-2025)
11 Supply Chain and Sales Channel analysis
11.1 Self Injection Device Supply Chain Analysis
11.2 Self Injection Device Key Raw Materials and Upstream Suppliers
11.3 Self Injection Device Clients Analysis
11.4 Self Injection Device Sales Channel and Sales Model Analysis
11.4.1 Self Injection Device Distribution Channel Analysis: Indirect Sales VS Direct Sales
11.4.2 Self Injection Device Distribution Channel Analysis: Online Sales VS Offline Sales
11.4.3 Self Injection Device Distributors
12 Self Injection Device Market Dynamics
12.1 Self Injection Device Industry Trends
12.2 Self Injection Device Market Drivers
12.3 Self Injection Device Market Challenges
12.4 Self Injection Device Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
Novo Nordisk
Mylan
Pfizer
Sanofi
BD
Eli Lilly
Gerresheimer
Dongbao
Ypsomed
Owen Mumford
Antares Pharma
Haselmeier
听
听
*If Applicable.
